Get more replies from employers
Send a job-specific resume in minutes.
Immunome, Inc. is seeking a Scientist II / Senior Scientist in ADME to design and execute nonclinical PK/PKPD/ADME strategies for oncology candidates from discovery through development.
You'll partner with cross-functional teams to deliver high-quality data informing decisions and regulatory submissions. You will work on multiple modalities, with emphasis on ADC programs, reporting to the Executive Director, Head of ADME.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.
The Scientist II / Senior Scientist , ADME will contribute to the design and execution of nonclinical pharmacokinetics/ PKPD/ ADME strategies to support oncology drug candidates from discovery through development. This role will partner closely with cross-functional teams to deliver high-quality data that informs decision-making and regulatory submissions. Reporting to the Executive Director, Head of ADME, the Scientist II will work on multiple modalities, with a strong emphasis on ADC programs.
Level andcompensationwillbecommensuratewith relevant experience.
Washington State Pay Range
$149,930 - $203,961 USD
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.